- Home
- KRMD vs VERU Comparison
KRMD vs VERU Comparison
Compare KRMD & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- VERU
- Stock Information
- Founded
- KRMD 1980
- VERU 1971
- Country
- KRMD United States
- VERU United States
- Employees
- KRMD N/A
- VERU N/A
- Industry
- KRMD Medical/Dental Instruments
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- VERU Health Care
- Exchange
- KRMD Nasdaq
- VERU Nasdaq
- Market Cap
- KRMD 134.3M
- VERU 94.5M
- IPO Year
- KRMD N/A
- VERU 1990
- Fundamental
- Price
- KRMD $3.62
- VERU $0.61
- Analyst Decision
- KRMD Strong Buy
- VERU Strong Buy
- Analyst Count
- KRMD 4
- VERU 2
- Target Price
- KRMD $4.63
- VERU $4.00
- AVG Volume (30 Days)
- KRMD 456.1K
- VERU 2.8M
- Earning Date
- KRMD 08-06-2025
- VERU 08-07-2025
- Dividend Yield
- KRMD N/A
- VERU N/A
- EPS Growth
- KRMD N/A
- VERU N/A
- EPS
- KRMD N/A
- VERU N/A
- Revenue
- KRMD $35,083,740.00
- VERU $16,886,419.00
- Revenue This Year
- KRMD $18.16
- VERU N/A
- Revenue Next Year
- KRMD $14.60
- VERU N/A
- P/E Ratio
- KRMD N/A
- VERU N/A
- Revenue Growth
- KRMD 19.65
- VERU 134.43
- 52 Week Low
- KRMD $1.86
- VERU $0.45
- 52 Week High
- KRMD $5.05
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- KRMD 68.65
- VERU 50.20
- Support Level
- KRMD $3.45
- VERU $0.57
- Resistance Level
- KRMD $3.77
- VERU $0.73
- Average True Range (ATR)
- KRMD 0.22
- VERU 0.05
- MACD
- KRMD 0.02
- VERU -0.01
- Stochastic Oscillator
- KRMD 85.48
- VERU 23.59
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.